Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.51 USD | -5.65% |
|
-2.45% | -.--% |
Jul. 09 | Cosmos Health to Manufacture 500,000 Units of CBD Products For Australian Firm | MT |
Jul. 02 | Cosmos Health Expands Collaboration with Papaellinas in Cyprus | CI |
Financials (USD)
Sales 2023 * | 51.29M | Sales 2024 * | 63.98M | Capitalization | 23.58M |
---|---|---|---|---|---|
Net income 2023 * | -7M | Net income 2024 * | -8M | EV / Sales 2023 * | 0.46 x |
Net cash position 2023 * | - | Net cash position 2024 * | - | EV / Sales 2024 * | 0.37 x |
P/E ratio 2023 * |
-2.19
x | P/E ratio 2024 * |
-2.98
x | Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 86.51% |
1 day | -5.65% |
Managers | Title | Age | Since |
---|---|---|---|
Grigorios Siokas
CEO | Chief Executive Officer | 58 | 16-02-25 |
George Terzis
DFI | Director of Finance/CFO | 42 | 20-11-10 |
Niko Bardakis
COO | Chief Operating Officer | 55 | 23-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 64 | 22-04-27 | |
Director/Board Member | 57 | 14-01-12 | |
Grigorios Siokas
CEO | Chief Executive Officer | 58 | 16-02-25 |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.72% | 75.74B | |
-4.79% | 23.24B | |
+17.81% | 8.76B | |
-31.67% | 6.69B | |
+20.57% | 5.58B | |
+4.12% | 4.22B | |
-3.94% | 3.99B | |
+14.96% | 3.39B | |
+10.59% | 3.23B |
- Stock Market
- Equities
- COSM Stock
- COSM Stock